Review



clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16
    Figure 3. Membrane permeabilization assays of 16 in <t>E.</t> <t>coli</t> ATCC 25922. Polymyxin B was included as a comparator membrane-targeting agent. Both 16 and polymyxin B were used at concentrations ranging from 1/32X to 1/2X the minimum inhibitory concentration (MIC), with the MIC values of 16 and polymyxin B being 100 and 1.56 µg/ml, respectively. The compound vehicle was DMSO. (A,B) Impact of E. coli treatment with 16 (A) or polymyxin B (B) on the intensity of the fluorophore N- phenyl-1-naphthylamine (NPN) at a concentration of 10 µM. (C,D) Impact of treatment with 16 (C) or polymyxin B (D) on the percentage of E. coli cells stained with the fluorophore propidium iodide (PI) at a concentration of 50 µM.
    Clarithromycin Against E Coli Atcc 25922 In Vitro Graphical Abstract Compound 16, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 40168 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/clarithromycin+against+e+coli+atcc+25922+in+vitro+graphical+abstract+compound+16/Escherichia+coli/10__1016_slash_j__ejmech__2019__05__075-11-24-28
    Average 99 stars, based on 40168 article reviews
    clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16 - by Bioz Stars, 2026-10
    99/100 stars

    Images

    1) Product Images from "Structure-activity relationships of potentiators of the antibiotic activity of clarithromycin against Escherichia coli"

    Article Title: Structure-activity relationships of potentiators of the antibiotic activity of clarithromycin against Escherichia coli

    Journal: European Journal of Medicinal Chemistry

    doi: 10.1016/j.ejmech.2019.05.075

    Figure 3. Membrane permeabilization assays of 16 in E. coli ATCC 25922. Polymyxin B was included as a comparator membrane-targeting agent. Both 16 and polymyxin B were used at concentrations ranging from 1/32X to 1/2X the minimum inhibitory concentration (MIC), with the MIC values of 16 and polymyxin B being 100 and 1.56 µg/ml, respectively. The compound vehicle was DMSO. (A,B) Impact of E. coli treatment with 16 (A) or polymyxin B (B) on the intensity of the fluorophore N- phenyl-1-naphthylamine (NPN) at a concentration of 10 µM. (C,D) Impact of treatment with 16 (C) or polymyxin B (D) on the percentage of E. coli cells stained with the fluorophore propidium iodide (PI) at a concentration of 50 µM.
    Figure Legend Snippet: Figure 3. Membrane permeabilization assays of 16 in E. coli ATCC 25922. Polymyxin B was included as a comparator membrane-targeting agent. Both 16 and polymyxin B were used at concentrations ranging from 1/32X to 1/2X the minimum inhibitory concentration (MIC), with the MIC values of 16 and polymyxin B being 100 and 1.56 µg/ml, respectively. The compound vehicle was DMSO. (A,B) Impact of E. coli treatment with 16 (A) or polymyxin B (B) on the intensity of the fluorophore N- phenyl-1-naphthylamine (NPN) at a concentration of 10 µM. (C,D) Impact of treatment with 16 (C) or polymyxin B (D) on the percentage of E. coli cells stained with the fluorophore propidium iodide (PI) at a concentration of 50 µM.

    Techniques Used: Membrane, Concentration Assay, Staining

    Figure 4. Assay for inhibition of the efflux of the fluorophore Hoechst 33342 (H33342) by 16 in E. coli ATCC 25922. When present, 16 was used at concentrations ranging from 1/32X to 1/2X MIC (3.13 to 50 µg/mL). All reactions were initiated by the addition of 50 mM glucose except where indicated. H33342 was used at a concentration of 10 µM. Compound vehicle was DMSO.
    Figure Legend Snippet: Figure 4. Assay for inhibition of the efflux of the fluorophore Hoechst 33342 (H33342) by 16 in E. coli ATCC 25922. When present, 16 was used at concentrations ranging from 1/32X to 1/2X MIC (3.13 to 50 µg/mL). All reactions were initiated by the addition of 50 mM glucose except where indicated. H33342 was used at a concentration of 10 µM. Compound vehicle was DMSO.

    Techniques Used: Inhibition, Concentration Assay

    Related Articles

    In Vitro:

    Article Title: Structure-activity relationships of potentiators of the antibiotic activity of clarithromycin against Escherichia coli
    Article Snippet: .. M AN US CR IP T AC CE PT ED Graphical Abstract Compound 16 is associated with a 32-fold enhancement in the potency of clarithromycin against E. coli ATCC 25922 in vitro Graphical Abstract Compound 16 is associated with a 32-fold enhancement in the potency of clarithromycin against E. coli ATCC 25922 in vitro H2N H N NH2 16 H2N H N NH2 16 M AN US CR IP T AC CE PT ED -1- Structure-Activity Relationships of Potentiators of the Antibiotic Activity of Clarithromycin against Escherichia coli Gifty Blanksona, Ajit K. Parhia,c, Malvika Kaulb, Daniel S. Pilchb and Edmond J. LaVoiea aDepartment of Medicinal Chemistry, Rutgers, The State University of New Jersey, Piscataway, New Jersey, 08820, U.S.A. bDepartment of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, U.S.A cTAXIS Pharmaceuticals, Inc., Monmouth Junction, New Jersey 08552, U.S.A. 1. ..

    Activity Assay:

    Article Title: Structure-activity relationships of potentiators of the antibiotic activity of clarithromycin against Escherichia coli
    Article Snippet: .. M AN US CR IP T AC CE PT ED Graphical Abstract Compound 16 is associated with a 32-fold enhancement in the potency of clarithromycin against E. coli ATCC 25922 in vitro Graphical Abstract Compound 16 is associated with a 32-fold enhancement in the potency of clarithromycin against E. coli ATCC 25922 in vitro H2N H N NH2 16 H2N H N NH2 16 M AN US CR IP T AC CE PT ED -1- Structure-Activity Relationships of Potentiators of the Antibiotic Activity of Clarithromycin against Escherichia coli Gifty Blanksona, Ajit K. Parhia,c, Malvika Kaulb, Daniel S. Pilchb and Edmond J. LaVoiea aDepartment of Medicinal Chemistry, Rutgers, The State University of New Jersey, Piscataway, New Jersey, 08820, U.S.A. bDepartment of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, U.S.A cTAXIS Pharmaceuticals, Inc., Monmouth Junction, New Jersey 08552, U.S.A. 1. ..



    Similar Products

    clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16  (ATCC)
    99
    ATCC clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16
    Figure 3. Membrane permeabilization assays of 16 in <t>E.</t> <t>coli</t> ATCC 25922. Polymyxin B was included as a comparator membrane-targeting agent. Both 16 and polymyxin B were used at concentrations ranging from 1/32X to 1/2X the minimum inhibitory concentration (MIC), with the MIC values of 16 and polymyxin B being 100 and 1.56 µg/ml, respectively. The compound vehicle was DMSO. (A,B) Impact of E. coli treatment with 16 (A) or polymyxin B (B) on the intensity of the fluorophore N- phenyl-1-naphthylamine (NPN) at a concentration of 10 µM. (C,D) Impact of treatment with 16 (C) or polymyxin B (D) on the percentage of E. coli cells stained with the fluorophore propidium iodide (PI) at a concentration of 50 µM.
    Clarithromycin Against E Coli Atcc 25922 In Vitro Graphical Abstract Compound 16, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/clarithromycin+against+e+coli+atcc+25922+in+vitro+graphical+abstract+compound+16/Escherichia+coli/10__1016_slash_j__ejmech__2019__05__075-11-24-28
    Average 99 stars, based on 1 article reviews
    clarithromycin against e coli atcc 25922 in vitro graphical abstract compound 16 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 3. Membrane permeabilization assays of 16 in E. coli ATCC 25922. Polymyxin B was included as a comparator membrane-targeting agent. Both 16 and polymyxin B were used at concentrations ranging from 1/32X to 1/2X the minimum inhibitory concentration (MIC), with the MIC values of 16 and polymyxin B being 100 and 1.56 µg/ml, respectively. The compound vehicle was DMSO. (A,B) Impact of E. coli treatment with 16 (A) or polymyxin B (B) on the intensity of the fluorophore N- phenyl-1-naphthylamine (NPN) at a concentration of 10 µM. (C,D) Impact of treatment with 16 (C) or polymyxin B (D) on the percentage of E. coli cells stained with the fluorophore propidium iodide (PI) at a concentration of 50 µM.

    Journal: European Journal of Medicinal Chemistry

    Article Title: Structure-activity relationships of potentiators of the antibiotic activity of clarithromycin against Escherichia coli

    doi: 10.1016/j.ejmech.2019.05.075

    Figure Lengend Snippet: Figure 3. Membrane permeabilization assays of 16 in E. coli ATCC 25922. Polymyxin B was included as a comparator membrane-targeting agent. Both 16 and polymyxin B were used at concentrations ranging from 1/32X to 1/2X the minimum inhibitory concentration (MIC), with the MIC values of 16 and polymyxin B being 100 and 1.56 µg/ml, respectively. The compound vehicle was DMSO. (A,B) Impact of E. coli treatment with 16 (A) or polymyxin B (B) on the intensity of the fluorophore N- phenyl-1-naphthylamine (NPN) at a concentration of 10 µM. (C,D) Impact of treatment with 16 (C) or polymyxin B (D) on the percentage of E. coli cells stained with the fluorophore propidium iodide (PI) at a concentration of 50 µM.

    Article Snippet: M AN US CR IP T AC CE PT ED Graphical Abstract Compound 16 is associated with a 32-fold enhancement in the potency of clarithromycin against E. coli ATCC 25922 in vitro Graphical Abstract Compound 16 is associated with a 32-fold enhancement in the potency of clarithromycin against E. coli ATCC 25922 in vitro H2N H N NH2 16 H2N H N NH2 16 M AN US CR IP T AC CE PT ED -1- Structure-Activity Relationships of Potentiators of the Antibiotic Activity of Clarithromycin against Escherichia coli Gifty Blanksona, Ajit K. Parhia,c, Malvika Kaulb, Daniel S. Pilchb and Edmond J. LaVoiea aDepartment of Medicinal Chemistry, Rutgers, The State University of New Jersey, Piscataway, New Jersey, 08820, U.S.A. bDepartment of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, U.S.A cTAXIS Pharmaceuticals, Inc., Monmouth Junction, New Jersey 08552, U.S.A. 1.

    Techniques: Membrane, Concentration Assay, Staining

    Figure 4. Assay for inhibition of the efflux of the fluorophore Hoechst 33342 (H33342) by 16 in E. coli ATCC 25922. When present, 16 was used at concentrations ranging from 1/32X to 1/2X MIC (3.13 to 50 µg/mL). All reactions were initiated by the addition of 50 mM glucose except where indicated. H33342 was used at a concentration of 10 µM. Compound vehicle was DMSO.

    Journal: European Journal of Medicinal Chemistry

    Article Title: Structure-activity relationships of potentiators of the antibiotic activity of clarithromycin against Escherichia coli

    doi: 10.1016/j.ejmech.2019.05.075

    Figure Lengend Snippet: Figure 4. Assay for inhibition of the efflux of the fluorophore Hoechst 33342 (H33342) by 16 in E. coli ATCC 25922. When present, 16 was used at concentrations ranging from 1/32X to 1/2X MIC (3.13 to 50 µg/mL). All reactions were initiated by the addition of 50 mM glucose except where indicated. H33342 was used at a concentration of 10 µM. Compound vehicle was DMSO.

    Article Snippet: M AN US CR IP T AC CE PT ED Graphical Abstract Compound 16 is associated with a 32-fold enhancement in the potency of clarithromycin against E. coli ATCC 25922 in vitro Graphical Abstract Compound 16 is associated with a 32-fold enhancement in the potency of clarithromycin against E. coli ATCC 25922 in vitro H2N H N NH2 16 H2N H N NH2 16 M AN US CR IP T AC CE PT ED -1- Structure-Activity Relationships of Potentiators of the Antibiotic Activity of Clarithromycin against Escherichia coli Gifty Blanksona, Ajit K. Parhia,c, Malvika Kaulb, Daniel S. Pilchb and Edmond J. LaVoiea aDepartment of Medicinal Chemistry, Rutgers, The State University of New Jersey, Piscataway, New Jersey, 08820, U.S.A. bDepartment of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, U.S.A cTAXIS Pharmaceuticals, Inc., Monmouth Junction, New Jersey 08552, U.S.A. 1.

    Techniques: Inhibition, Concentration Assay